Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy-Reference-Cited by-同舟云学术

Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy

Published:2019-06-17 Issue:27 Volume:11 Page:23926-23937
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Bertucci Alessandro¹,Kim Kang-Hoon,Kang Jinyoung,Zuidema Jonathan M.,Lee Seo Hyeon,Kwon Ester J.,Kim Dokyoung,Howell Stephen B.,Ricci Francesco¹^ORCID,Ruoslahti Erkki²,Jang Hyeung-Jin,Sailor Michael J.^ORCID

Affiliation:

1. Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Rome, 00133, Italy

2. Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States

Funder

National Cancer Institute

National Eye Institute

Division of Molecular and Cellular Biosciences

National Research Foundation of Korea

H2020 Marie Sklodowska-Curie Actions

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.9b07980

Reference80 articles.

1. Cancer statistics, 2018

2. Ovarian cancer

3. Overcoming platinum resistance in ovarian carcinoma

4. MicroRNA Signatures in Human Ovarian Cancer

5. Current status and implications of microRNAs in ovarian cancer diagnosis and therapy

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review;Oncology Letters;2024-08-12

2. Porous silicon and silica carriers for delivery of peptide therapeutics;Drug Delivery and Translational Research;2024-05-31

3. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial–Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer;Cells;2024-05-10

4. Delivery of miRNAs Using Porous Silicon Nanoparticles Incorporated into 3D Hydrogels Enhances MSC Osteogenesis by Modulation of Fatty Acid Signaling and Silicon Degradation;Advanced Healthcare Materials;2024-05-03

5. LDLR-Mediated Targeting and Productive Uptake of siRNA-Peptide Ligand Conjugates In Vitro and In Vivo;Pharmaceutics;2024-04-17